Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects

NCT00132405 is registered in ClinicalTrials.gov with AlgoRx Pharmaceuticals as lead sponsor.

NCT NCT00132405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effectiveness and Safety of ALGRX 3268 0.5 Mg/20 Bar at the Back of the Hand in Pediatric Subjects
Lead sponsor
AlgoRx Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
September 30, 2004
Enrollment
260
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain